Human Microbiome in Health and Disease - Part A

Erscheinungsjahr 2022
ISBN: 978-0-323-99786-7
Verlag: William Andrew Publishing

Buch, Englisch, 300 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 590 g

Human Microbiome in Health and Disease, Volume 191, Part A presents updated knowledge on human microbiome as covered by renowned science faculty across the globe. Chapters in this volume include an introduction to human microbiome, Structure, functions and diversity of healthy human microbiome, Role of human microbiome in cancer, Gut microbiota and gastrointestinal cancer, Dysbiosis of human microbiome and metabolic diseases, Gut microbiome and type 2 diabetes, Gut microbiome and non-alcoholic fatty liver disease, Hepatic drug metabolism and intestinal microbiota, Emerging tools for understanding the human microbiome, and Microbiome therapeutics: Opportunity and challenges, and more.

These chapters cover the composition, diversity, dynamics and functions of human microbiome in health and disease. This book will form an excellent and informative text on keystone, autochthonous, and exogenous microbiota important for human health in a simple to understand and easy to read format.

Zielgruppe

<p>Basic researchers, Clinicians, Pharmacologists, Graduate students</p>

Autoren/Hrsg.

Weitere Mitwirkende

Das, Bhabatosh

Singh, Vijai

Fachgebiete

• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

Preface Bhabatosh Das and Vijai Singh 1. An introduction to human microbiome Bhabatosh Das 2. Emerging tools for understanding the human microbiome Tarini Shankar Ghosh and Mrinmoy Das 3. Structure, functions, and diversity of the healthy human microbiome Taruna Ahrodia, Santanu Das, Susmita Bakshi and Bhabatosh Das 4. An overview of cancer and the human microbiome Soumendu Mahapatra, Smrutishree Mohanty, Rasmita Mishra and Punit Prasad 5. Gut microbiota in gastrointestinal diseases Gargi Bhattacherjee, Khushal Khambhati, Nisarg Gohil, Priyanka Singh, Jigresh Gohil, Bijun Snehi, Rupesh Maurya, Dinh-Toi Chu, Suresh Ramakrishna and Vijai Singh 6. Gut dysbiosis and metabolic diseases Purbita Bandopadhyay and Dipyaman Ganguly 7. Gut microbiome and type 2 diabetes Sweta Patel, Sriram Seshadri and Sarat Dalai 8. Gut microbiome and non-alcoholic fatty liver disease Ayushi Purohit, Md Jahangir Alam, Bharti Kandiyal, Shalimar, Bhabatosh Das and Sanjay K. Banerjee 9. Hepatic drug metabolism and gut microbiome Tanshi Mehrotra and Subir Kumar Maulik 10. Microbiome-based therapeutics: Opportunity and challenges Archana Pant and Bhabatosh Das

Über Autor(innen)

Das, Bhabatosh
Dr Bhabatosh Das is an Associate Professor in Translational Health Science and Technology Institute, an autonomous institute of the Department of Biotechnology, Government of India. He received his MSc degree (2000) from Visva-Bharati University, MTech degree (2002) from IIT-Kharagpur and PhD (2008) from IICB-Kolkata. He moved to France for his postdoctoral training and joined I2BC, France. Dr. Das is recipient of two international fellowships (i) CNRS, Govt. of France (ii) JSPS, Govt. of Japan and three national fellowships (i) IIT (ii) ICMR (iii) CSIR, Govt. of India. He has published 71 research articles 12 book chapters and received more than 2150 citations. Currently, he is Adjunct Visiting Faculty at MAHE-Manipal; Visiting Faculty at NIPER-Guwahati; Adjunct Faculty at RCB-Faridabad; Guest Lecturer at AIIMS-New Delhi. Dr. Das is Editorial Board Member in (i) Microbial Ecology (Springer group) (ii) Gut Microbiome (Cambridge University Press) and (iii) Current Indian Science (Bentham Science). He is guest associate editor in (i) Frontiers in Microbiology (ii) Frontiers in Genetics and (iii) Progress in Molecular Biology and Translational Research. He is a member in (i) GTFCC, WHO (ii) The Nutrition Society, London, UK and (iii) American Society for Microbiology, USA (Former). His current research focuses is Human microbiome and Bacterial antimicrobial resistance.

Singh, Vijai
Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Associate Professor in the Department of Biosciences, School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. Prior this this, he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 100 articles, 70 chapters, 15 books and 3 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.